US › Healthcare

Airsculpt Technologies Inc (AIRS)

US · Healthcare · Medical Care Facilities

$2.30+9.26%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$42.9M

Revenue YoY

-2.5%

Net profit

$-1.1M

EPS

$-0.02

EPS estimate

$0.02

Net margin

-2.6%

EPS came in at -0.02 against a street estimate of 0.02 — a miss of 200.0%.

Key statistics

Market cap

$174.5M

Forward P/E

0.0

P/B

1.65

Book value

$1.47

EPS (TTM)

$-0.18

52-week high

$12.00

52-week low

$1.51

50-day MA

$3.74

200-day MA

$3.28

Beta

2.29

Analyst view

Analysts rate Airsculpt Technologies Inc a hold (0 buy, 4 hold, 0 sell out of 4) with an average price target of $4.50.

Shareholding

Insiders

42.14%

Institutions

63.36%

Largest institutional holders

Fund	Stake
Vesey Street Capital Partners, L.L.C.	42.06%
Balyasny Asset Management LLC	3.23%
BlackRock Inc	1.12%
FourWorld Capital Management LLC	1.04%
Wexford Capital LP	0.93%
UBS Group AG	0.86%
Susquehanna International Group, LLP	0.66%
GSA Capital Partners LLP	0.59%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Airsculpt Technologies Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.